Does GEMCITABINE Cause Hypertransaminasaemia? 196 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Hypertransaminasaemia have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.6% of all adverse event reports for GEMCITABINE.
196
Reports of Hypertransaminasaemia with GEMCITABINE
0.6%
of all GEMCITABINE reports
7
Deaths
29
Hospitalizations
How Dangerous Is Hypertransaminasaemia From GEMCITABINE?
Of the 196 reports, 7 (3.6%) resulted in death, 29 (14.8%) required hospitalization, and 10 (5.1%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
DEXAMETHASONE (169)
RITUXIMAB (168)
Which GEMCITABINE Alternatives Have Lower Hypertransaminasaemia Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN